2021 Annual Meeting | Sleep Posters

Date/Time This program spans the entire conference

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Sleep

CME Available 0.00 credit

Event Timeline
07:00 AM - 05:00 PM EDT	Abstract	001 - Incremental Healthcare Burden of Insomnia among Alzheimer’s Disease Patients with and without Underlying Depression Zaina Qureshi
07:00 AM - 05:00 PM EDT	Abstract	002 - Exploratory Study of Acoustic Neuromodulation Improves Caregiver Burden, Insomnia, Stress, Anxiety, and Autonomic Function Charles H. Tegeler, MD
07:00 AM - 05:00 PM EDT	Abstract	003 - Factors associated with insomnia in the Peruvian population during social isolation due to the COVID-19 pandemic
07:00 AM - 05:00 PM EDT	Abstract	004 - How Chronic Nausea/Vomiting Worsen Restorative Quality of Sleep in a Longitudinal Study of the American General Population Maurice M. Ohayon, MD, PhD, DSc
07:00 AM - 05:00 PM EDT	Abstract	005 - Insomnia treatments and on-the-road driving performance: a systematic literature review Genevieve Meier
07:00 AM - 05:00 PM EDT	Abstract	006 - A Pilot, Placebo-controlled Trial of Closed-loop Acoustic Stimulation Neurotechnology for Insomnia Charles H. Tegeler, MD
07:00 AM - 05:00 PM EDT	Abstract	007 - Evaluation of Next-Dose Transition from Zolpidem to Lemborexant for the Treatment of Insomnia: A Multicenter Open-label Pilot Study Russell Rosenberg
07:00 AM - 05:00 PM EDT	Abstract	008 - Effect of Lemborexant on Fatigue Severity and Sleep Outcomes Over 12 Months in Subjects With Clinically Significant Fatigue at Baseline Craig Chepke
07:00 AM - 05:00 PM EDT	Abstract	009 - Responder Profiles Over 12 Months for Sleep Onset and Sleep Maintenance Outcomes with Lemborexant Gary Zammit
07:00 AM - 05:00 PM EDT	Abstract	010 - Effect of Lemborexant on Patient-Reported Distress About Sleeping and Interference with Daily Functioning in Subjects With Insomnia Craig Chepke
07:00 AM - 05:00 PM EDT	Abstract	011 - Daytime Sleepiness, Sleep Quality, Hallucinations, and Sleep Paralysis in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation Michael J. Thorpy, MD
07:00 AM - 05:00 PM EDT	Abstract	012 - Polysomnographic Measures of Sleep Continuity in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation Yves Dauvilliers, MD, PhD
07:00 AM - 05:00 PM EDT	Abstract	013 - Lower-Sodium Oxybate Dose Titration and Transition From Sodium Oxybate in a Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adult Participants With Narcolepsy With Cataplexy Nancy R. Foldvary-Schaefer, DO, FAAN
07:00 AM - 05:00 PM EDT	Abstract	014 - Cataplexy-Free Days in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study of Lower-Sodium Oxybate in Adults With Narcolepsy With Cataplexy Yves Dauvilliers, MD, PhD
07:00 AM - 05:00 PM EDT	Abstract	015 - Time to Onset of Clinical Response During Treatment With Pitolisant Craig Davis, PhD
07:00 AM - 05:00 PM EDT	Abstract	016 - Cardiac Safety Profile of Pitolisant in Patients With Narcolepsy William C. Winter
07:00 AM - 05:00 PM EDT	Abstract	017 - Safety and efficacy of TAK-925 in adults with obstructive sleep apnea who experience excessive daytime sleepiness despite adequate use of CPAP Richard K. Bogan, MD
07:00 AM - 05:00 PM EDT	Abstract	018 - The role of marriage and sleep efficiency in cognitive decline: Results from Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Natalia Rincon, MD
07:00 AM - 05:00 PM EDT	Abstract	019 - Subjective sleep disturbances are not associated with objective cognitive functional impairment in Parkinson’s disease Samantha K. Holden, MD, MS, FAAN
07:00 AM - 05:00 PM EDT	Abstract	020 - Evaluating Closed-loop Auditory Stimulation during Sleep as an Intervention to Improve Memory Consolidation Bryan Baxter, PhD
07:00 AM - 05:00 PM EDT	Abstract	021 - Supine Sleep, Sleep Apnea and Sleep Architecture: A Cross-sectional Study in Adults Kathy K. Xiong, MD
07:00 AM - 05:00 PM EDT	Abstract	022 - Association of Mild vs Moderate REM Predominant OSA with Prevalence of Various Cardiovascular, Cerebrovascular Comorbidities: A Retrospective Analysis of Data From Sleep Laboratory at Cabell Huntington Hospital, WV. Dipali P. Nemade, MD
07:00 AM - 05:00 PM EDT	Abstract	023 - Strengthening Oropharyngeal Muscles as a Novel Approach to Treat Obstructive Sleep Apnea after Stroke: A Randomized Feasibility Study Reeman Marzouqah, MSc
07:00 AM - 05:00 PM EDT	Abstract	024 - Diagnostic Thresholds for REM Sleep Without Atonia in Idiopathic/Isolated REM Sleep Behavior Disorder in the North American Prodromal Synucleinopathy (NAPS) Cohort John C. Feemster, MD
07:00 AM - 05:00 PM EDT	Abstract	025 - Chronic Nausea/Vomiting as a Risk Factor for Restless Legs Syndrome in a Longitudinal Study of the American General Population Maurice M. Ohayon, MD, PhD, DSc
07:00 AM - 05:00 PM EDT	Abstract	026 - Association between lower limb post-fracture pseudoarthrosis and restless legs syndrome Joaquin Ojeda, MD
07:00 AM - 05:00 PM EDT	Abstract	027 - Medical Treatment Options for Periodic Limb Movement Disorder and Restless Leg in the Pediatric Population. Nicole Goldberg-Boltz
07:00 AM - 05:00 PM EDT	Abstract	028 - Cytokines in the Central Disorders of Hypersomnolence Caroline Maness, MD
07:00 AM - 05:00 PM EDT	Abstract	029 - The Epworth Sleepiness Scale in Epilepsy: Internal Consistency and Disease-Related Associations Maeve M. Pascoe
07:00 AM - 05:00 PM EDT	Abstract	030 - Atypical Sleep Architecture in Children with 15q11.2-13.1 Duplication (Dup15q) Syndrome Vidya Saravanapandian, MS

Faculty Disclosures
Natalia Rincon, MD	Dr. Rincon has nothing to disclose.
Dipali P. Nemade, MD	Dr. Nemade has nothing to disclose.
Wassim Tarraf	No disclosure on file
Kiran P. Maski, MD	An immediate family member of Dr. Maski has received personal compensation for serving as an employee of Sanofi Genzyme. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Harmony Biosciences. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkermes. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KemPharm. Dr. Maski has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Maski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hayes Legal Services. An immediate family member of Dr. Maski has stock in Sanofi Genzyme. The institution of Dr. Maski has received research support from Jazz Pharmaceuticals. The institution of Dr. Maski has received research support from NIH 5K23NS104267-2. The institution of Dr. Maski has received research support from Coverys. Dr. Maski has received publishing royalties from a publication relating to health care.
	No disclosure on file
David R. Colelli, MSc	Mr. Colelli has nothing to disclose.
Carlos Perdomo	No disclosure on file
Brian J. Murray, MD, FAAN	The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Amelie Pelletier	Ms. Pelletier has nothing to disclose.
Russell Rosenberg	Mr. Rosenberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Mr. Rosenberg has received research support from Neurotrials Research.
Paul B. Ferguson, MD, FAAN	Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Ferguson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Ferguson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan.
Trevor Jairam, MD	Trevor Jairam has nothing to disclose.
Bryan Baxter, PhD	Dr. Baxter has received research support from American Academy of Neurology/American Brain Foundation/The McKnight Brain Research Foundation.
Jianwen Cai	No disclosure on file
Vidya Saravanapandian, MS	Miss Saravanapandian has nothing to disclose.
Margaret Moline	Margaret Moline has received personal compensation for serving as an employee of EISAI, INC.. Margaret Moline has received intellectual property interests from a discovery or technology relating to health care. Margaret Moline has received personal compensation in the range of $0-$499 for serving as a review, loan repayment program with NIH.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Laavanya Dharmakulaseelan, MD	Ms. Dharmakulaseelan has nothing to disclose.
Ariana Stickel	No disclosure on file
Hossam A. Shaltout, PhD	Dr. Shaltout has nothing to disclose.
Vikram Shivkumar, MD, FAAN	Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Shivkumar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion.
Gary Zammit	Gary Zammit has received personal compensation for serving as an employee of Clinilabs, Inc.. Gary Zammit has received stock or an ownership interest from Clinilabs, Inc. Gary Zammit has received stock or an ownership interest from Sleep Disorders Institute. Gary Zammit has received stock or an ownership interest from Home Sleep and Respiratory Care.
Tina Olsson, PhD	Dr. Olsson has received personal compensation for serving as an employee of Takeda.
John C. Feemster, MD	Mr. Feemster has nothing to disclose.
Stephen Wanaski, PhD	Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences.
Alberto Ramos, MD, FAAN	Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One Care Media, LLC. Dr. Ramos has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Heart, Lung and Blood Institute . The institution of Dr. Ramos has received research support from Axsome pharmaceutical. The institution of Dr. Ramos has received research support from NIH. The institution of Dr. Ramos has received research support from National Institutes of Aging/NIH. Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Clinical Advisor with Neurogeneces, Inc. Dr. Ramos has a non-compensated relationship as a Editorial Board with Chest Scientific Journal that is relevant to AAN interests or activities.
Yves Dauvilliers, MD, PhD	Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel.
Kenzie Brown	No disclosure on file
Dinesh Kumar	No disclosure on file
Richard K. Bogan, MD	Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Philips. The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Fresca. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care. Dr. Bogan has a non-compensated relationship as a Chair with National Sleep Foundation that is relevant to AAN interests or activities.
Madeleine M. Grigg-Damberger, MD	Dr. Grigg-Damberger has received personal compensation for serving as an employee of Oxford University Press. Dr. Grigg-Damberger has received personal compensation for serving as an employee of Up-to-date. Dr. Grigg-Damberger has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Sleep Medicine. Dr. Grigg-Damberger has received publishing royalties from a publication relating to health care.
Reeman Marzouqah, MSc	Ms. Marzouqah has nothing to disclose.
Ronald Postuma, MD	Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Clete A. Kushida, MD, PhD	Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Shaun Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MGC Pharma. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. Dr. Hussain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grenwich Biosciences.
Zaina Qureshi	Zaina Qureshi has received personal compensation for serving as an employee of Merck.
Samantha K. Holden, MD, MS, FAAN	Dr. Holden has nothing to disclose.
James P. Maynard, MD	Dr. Maynard has nothing to disclose.
Susana Lopez Gallardo	No disclosure on file
Roman Skowronski, MD, PhD	Dr. Skowronski has nothing to disclose.
Nicole Goldberg-Boltz	Miss Goldberg-Boltz has nothing to disclose.
Phyllis C. Zee, MD, PhD	Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Aventis. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals Inc.. Dr. Zee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Zee has received research support from National Institutes of Health. The institution of Dr. Zee has received research support from Vanda. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received intellectual property interests from a discovery or technology relating to health care. Dr. Zee has received publishing royalties from a publication relating to health care.
Craig Davis, PhD	Dr. Davis has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Davis has received stock or an ownership interest from Harmony Biosciences.
Brice V. McConnell, MD	The institution of Dr. McConnell has received research support from American Academy of Neurology.
Craig Chepke	Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Craig Chepke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Craig Chepke has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Neurocrine. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acadia. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Otsuka. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Takeda. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Janssen. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ironshore. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Craig Chepke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Craig Chepke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Intracellular. Craig Chepke has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Craig Chepke has received research support from Acadia. Craig Chepke has received research support from Harmony. Craig Chepke has received research support from Neurocrine.
Hector Gonzalez	Hector Gonzalez has nothing to disclose.
Jeffrey M. Dayno, MD	Dr. Dayno has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Dayno has received stock or an ownership interest from Harmony Biosciences.
Alon Y. Avidan, MD, MPH, FAAN	Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Avidan has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Avidan has received publishing royalties from a publication relating to health care.
Shafali Jeste, MD, FAAN	Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Jordan S. Dubow, MD	Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals.
Manoj Malhotra, MD	Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Maurice M. Ohayon, MD, PhD, DSc	The institution of Dr. Ohayon has received research support from Jazz pharmaceuticals. The institution of Dr. Ohayon has received research support from Takeda Pharmaceuticals.
LynnMarie Trotti, MD	Dr. Trotti has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Academy of Sleep Medicine. Dr. Trotti has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Association of Chest Physicians. The institution of Dr. Trotti has received research support from NIH. The institution of Dr. Trotti has received research support from American Academy of Sleep Medicine Foundation . Dr. Trotti has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with AASM, CHEST, Medscape, SRS Foundation, PER CME, Haymarket CME. Dr. Trotti has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH. Dr. Trotti has received personal compensation in the range of $0-$499 for serving as a Reviewer with Lancet journals. Dr. Trotti has a non-compensated relationship as a Medical advisory board member with Hypersomnia Foundation that is relevant to AAN interests or activities. Dr. Trotti has a non-compensated relationship as a Board member with AASM Foundation that is relevant to AAN interests or activities. Dr. Trotti has a non-compensated relationship as a Board member with ABSM that is relevant to AAN interests or activities.
Lindsay J. Howard	Ms. Howard has nothing to disclose.
Yo-El Ju, MD	The institution of Dr. Ju has received research support from National Institutes of Health.
William C. Winter	Mr. Winter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Mr. Winter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Harmony Bioscience. Mr. Winter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Mr. Winter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Harmony Bioscience. Mr. Winter has received personal compensation in the range of $10,000-$49,999 for serving as a Advisor with TempurPEDIC. Mr. Winter has received personal compensation in the range of $100,000-$499,999 for serving as a Advisor with MattressFirm.
Erik K. St. Louis, MD	Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Divya S. Nadkarni, MD	Dr. Nadkarni has nothing to disclose.
Maeve M. Pascoe	Ms. Pascoe has nothing to disclose.
Sejal V. Jain, MD	Dr. Jain has nothing to disclose.
Dara S. Manoach, MD	The institution of Dr. Manoach has received research support from NIMH. The institution of Dr. Manoach has received research support from MGH ECOR.
Dawn Kellar	No disclosure on file
Robert P. Rubens, MD, MBA, FAAN	Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
Albena I. Patroneva, MD	Dr. Patroneva has nothing to disclose.
Jennifer S. McLeland	Ms. McLeland has nothing to disclose.
Josiane Broussard	No disclosure on file
Martha Daviglus	No disclosure on file
Michael J. Thorpy, MD	Dr. Thorpy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Judi Profant, PhD	No disclosure on file
Stuart McCarter, MD	Dr. McCarter has received research support from NIH.
Mark Boulos, MD	Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin Labs. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from Slamen-Fast New Initiatives in Neurology Award. The institution of Dr. Boulos has received research support from Green Mountain . The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and Education in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a speaker with Jazz Pharmaceuticals.
Nancy R. Foldvary-Schaefer, DO, FAAN	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Genevieve Meier	Genevieve Meier has received personal compensation for serving as an employee of Eisai.
Joaquin Ojeda, MD	Dr. Ojeda has nothing to disclose.
Robert Alexander, MD	Dr. Alexander has received personal compensation for serving as an employee of Takeda .
Catherine Tegeler	Ms. Tegeler has nothing to disclose.
Linda Gallo	Linda Gallo has nothing to disclose.
Charles H. Tegeler, MD	Dr. Tegeler has nothing to disclose.
David J. Seiden, MD	Dr. Seiden has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Dr. Seiden has received stock or an ownership interest from Avadel Pharmaceuticals.
Thomas Roth, PhD	Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Roth has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Avadel. Dr. Roth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz.
Caroline Maness, MD	Dr. Maness has nothing to disclose.
Brian Berman, MD, MS, FAAN	Dr. Berman has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for International Parkinson and Movement Disorder Society. The institution of Dr. Berman has received research support from Dystonia Medical Research Foundation. The institution of Dr. Berman has received research support from Administration for Community Living. The institution of Dr. Berman has received research support from The Parkinson Foundation. The institution of Dr. Berman has received research support from National Institutes of Health.
Kathy K. Xiong, MD	Miss Xiong has nothing to disclose.